Skip to main content

Table 3 Bivariate analysis of risk factors for Left ventricular Hypertrophy among hypertensive patients in Ethiopia

From: Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors

Predictor variables

LVH ( N = 200 )

P-value

 

Yes, N (%)

No, N (%)

 

Sex

Female

78(68.4)

36(31.6)

<0.001

Male

26(30.2)

60(69.8)

Age

≥50 years

92(61.7)

57(38.3)

<0.001

<50 years

12(23.5 )

39(76.5)

BMI

≥25 Kg/m2

40(57.1)

30(42.9)

0.172

<25 Kg/m2

64(49.2)

66(50.8)

SBP

≥140 mmHg

65(63.7)

37(36.3)

<0.001

<140 mmHg

39(39.8)

59(60.2)

DBP

≥90 mmHg

56(56.0)

44(44.0)

0.258

<90 mmHg

48(48.0)

52(52.0)

History of DM

Yes

20(51.3)

19(48.7)

0.920

No

84(52.2)

77(47.8)

Type of DM

Type 2

15(53.6)

13(46.4)

0.897

Type 1

5(45.5)

6(54.5)

ACE inhibitor

No

86(74.1)

30(25.9)

<0.001

Yes

18(21.4)

66(78.6)

Beta Blocker

Yes

43(57.3)

32(42.7)

0.242

No

61(48.8)

64(51.2)

Duration of hypertension

≥10 years

88(62.9)

52(37.1)

<0.001

<10 years

16(26.7)

44(73.3)

Thiazide diuretic

Yes

54(50.9)

52(49.1)

0.751

No

50(53.2)

44(46.8)

Calcium channel blocker

Yes

9(47.4)

10(52.6)

0.671

 

No

95(52.5)

86(47.5)

 
  1. DM – diabetes mellitus, ACE – angiotensin converting enzyme.